Most importantly, the data from the genetic silencing of PLCγ2 as well as PLCv1 were consistent with the pharmacological inhibitor features of Dex-induced B-ALL cell death (Supplementary Fig. 9a–d). The gene discussed is PLCG2; the disease is precursor B-cell acute lymphoblastic leukemia.